RACGP
US$ 20.43
semaglutide compound news Hims is in the crosshairs. What does it mean for compounding? FDA issues warning about some
Description
Rising GLP-1 usage is reshaping grocery spending, with profound implications for foodmakers and grocers
Discovered in 2015 at USC, early studies showed it prevents diet-induced obesity in mice by enhancing fat oxidation
Notably, low dose semaglutide treatment effectively reduced this intracardiac lipid accumulation by decreasing both the number and size of these lipid droplets ( Figure 1I )
Results could mark a "new era" in treating obesity with even more therapies on the horizon
